A3 Adenosine receptors mediate oligodendrocyte death and ischemic damage to optic nerve

GLIA

Volumn 62, Issue 2, 2014, Pages 199-216

  González Fernández, Estíbaliz ^a   Sánchez Gómez, María Victoria ^a   Pérez Samartín, Alberto ^a   Arellano, Rogelio O ^a,b   Matute, Carlos ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b INSTITUTO DE NEUROBIOLOGÍA   (Mexico)

Author keywords

Astrocytes; Caspases; Demyelinization; Ischemia; Mitochondria

Indexed keywords

9 CHLORO 2 (2 FURYL) 5 PHENYLACETYLAMINO 1,2,4 TRIAZOLO[1,5 C]QUINAZOLINE; ADENOSINE; CAFFEINE; CASPASE 3; MYELIN; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; CASPASE; DRUG DERIVATIVE; N(6) (3 IODOBENZYL) 5' N METHYLCARBOXAMIDOADENOSINE; N(6)-(3-IODOBENZYL)-5'-N-METHYLCARBOXAMIDOADENOSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; CELL DEATH; CONTROLLED STUDY; DISSOCIATED CELL CULTURE; ENZYME ACTIVATION; EX VIVO STUDY; ISCHEMIA; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; NONHUMAN; OLIGODENDROCYTE CULTURE; OLIGODENDROGLIA; OPTIC NERVE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; WHITE MATTER; ANIMAL; APOPTOSIS; ASTROCYTE; CELL CULTURE; CYTOLOGY; DEMYELINATION; DRUG EFFECT; METABOLISM; MITOCHONDRION; SPRAGUE DAWLEY RAT;

ASTROCYTES; CASPASES; DEMYELINIZATION; ISCHEMIA; MITOCHONDRIA;

ADENOSINE; ADENOSINE A3 RECEPTOR AGONISTS; ANIMALS; APOPTOSIS; CASPASE 3; CELLS, CULTURED; OLIGODENDROGLIA; OPTIC NERVE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A3;

EID: 84890214544     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22599     Document Type: Article

References (68)

1. Aghaei M, Panjehpour M, Karami-Tehrani F, Salami S. 2011. Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: Involvement of intrinsic pathway. J Cancer Res Clin Oncol 137:1511-1123.
2. Alberdi E, Sánchez-Gòmez MV, Marino A, Matute C. 2002. Ca2+ influx through AMPA or kainate receptors alone is sufficient to initiate excitotoxicity in cultured oligodendrocytes. Neurobiol Dis 9:234-243.
3. Alberdi E, Wyssenbach A, Alberdi M, Sánchez-Gómez MV, Cavaliere F, Rodríguez JJ, Verkhratsky A, Matute C. 2013. Ca2+-dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid b-treated astrocytes and in a model of Alzheimer's disease. Aging Cell 12:292-302.
4. Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J. 2006. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience 142:941-952.
5. Back SA, Craig A, Kayton RJ, Luo NL, Meshul CK, Allcock N, Fern R. 2007. Hypoxia-ischemia preferentially triggers glutamate depletion from oligodendroglia and axons in perinatal cerebral white matter. J Cereb Blood Flow Metab 27:334-347.
6. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, Raff MC. 1992. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70:31-46.
7. Bjorklund O, Shang M, Tonazzini I, Dare E, Fredholm BB. 2008. Adenosine A1 and A3 receptors protect astrocytes from hypoxic damage. Eur J Pharmacol 596:6-13.
8. Blum D, Hourez R, Galas MC, Popoli P, Schiffmann SN. 2003. Adenosine receptors and Huntington's disease: Implications for pathogenesis and therapeutics. Lancet Neurol 2:366-374.
9. Brady NR, Elmore SP, van Beek JJ, Krab K, Courtoy PJ, Hue L, Westerhoff HV. 2004. Coordinated behavior of mitochondria in both space and time: A reactive oxygen species-activated wave of mitochondrial depolarization. Biophys J 87:2022-2034.
10. Cao Q, Zhang LL, Hu ZY, Wu BY. 2010. [Protective effect of mild hypothermia on astrocytes with traumatic or ischemic injury]. Nan Fang Yi Ke Da Xue Xue Bao 30:61-63.
11. Cao X-h, Zhao S-s, Liu D-y, Wang Z, Niu L-l, Hou L-h, Wang C-l. 2011. ROS-Ca2+ is associated with mitochondria permeability transition pore involved in surfactin-induced MCF-7 cells apoptosis. Chem Biol Interact 190:16-27.
12. Conde SV, Obeso A, Vicario I, Rigual R, Rocher A, Gonzalez C. 2006. Caffeine inhibition of rat carotid body chemoreceptors is mediated by A2A and A2B adenosine receptors. J Neurochem 98:616-628.
13. Chen GQ, Chen YY, Wang XS, Wu SZ, Yang HM, Xu HQ, He JC, Wang XT, Chen JF, Zheng RY. 2010. Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats. Brain Res 1309:116-125.
14. Cheong SL, Federico S, Venkatesan G, Mandel AL, Shao YM, Moro S, Spalluto G, Pastorin G. 2013. The A3 adenosine receptor as multifaceted therapeutic target: Pharmacology, medicinal chemistry, and in silico approaches. Med Res Rev 33:235-335.
15. Daré E, Schulte G, Karovic O, Hammarberg C, Fredholm BB. 2007. Modulation of glial cell functions by adenosine receptors. Physiol Behav 92:15-20.
16. Domercq M, Perez-Samartin A, Aparicio D, Alberdi E, Pampliega O, Matute C. 2010. P2X7 receptors mediate ischemic damage to oligodendrocytes. Glia 58:730-740.
17. Dunwiddie TV, Masino SA. 2001. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24:31-55.
18. Fatokun AA, Stone TW, Smith RA. 2008. Adenosine receptor ligands protect against a combination of apoptotic and necrotic cell death in cerebellar granule neurons. Exp Brain Res 186:151-160.
19. Fern R, Moller T. 2000. Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J Neurosci 20:34-42.
20. Fredholm BB, AP IJ, Jacobson KA, Klotz KN, Linden J. 2001. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527-552.
21. Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Wasserman W. 2000. Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch Pharmacol 362:364-374.
22. Gabryel B, Bielecka A, Stolecka A, Bernacki J, Langfort J. 2010. Cytosolic phospholipase A(2) inhibition is involved in the protective effect of nortriptyline in primary astrocyte cultures exposed to combined oxygen-glucose deprivation. Pharmacol Rep 62:814-826.
23. Gallenne T, Gautier F, Oliver L, Hervouet E, Noel B, Hickman JA, Geneste O, Cartron PF, Vallette FM, Manon S and others. 2009. Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members. J Cell Biol 185:279-290.
24. Galluzzi L, Blomgren K, Kroemer G. 2009. Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci 10:481-494.
25. Goldenberg-Cohen N, Guo Y, Margolis F, Cohen Y, Miller NR, Bernstein SL. 2005. Oligodendrocyte dysfunction after induction of experimental anterior optic nerve ischemia. Invest Ophthalmol Vis Sci 46:2716-2725.
26. Green DR, Kroemer G. 2004. The pathophysiology of mitochondrial cell death. Science 305:626-629.
27. Hammarberg C, Fredholm BB, Schulte G. 2004. Adenosine A3 receptor-mediated regulation of p38 and extracellular-regulated kinase ERK1/2 via phosphatidylinositol-3′-kinase. Biochem Pharmacol 67:129-134.
28. Iijima T, Mishima T, Akagawa K, Iwao Y. 2006. Neuroprotective effect of propofol on necrosis and apoptosis following oxygen-glucose deprivation--relationship between mitochondrial membrane potential and mode of death. Brain Res 1099:25-32.
29. Itoh T, Itoh A, Pleasure D. 2003. Bcl-2-related protein family gene expression during oligodendroglial differentiation. J Neurochem 85:1500-1512.
30. Kim SJ, Min HY, Chung HJ, Park EJ, Hong JY, Kang YJ, Shin DH, Jeong LS, Lee SK. 2008. Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells. Cancer Lett 264:309-315.
31. Kim TH, Kim YK, Woo JS. 2012. The adenosine A3 receptor agonist Cl-IB-MECA induces cell death through Ca(2+)/ROS-dependent down regulation of ERK and Akt in A172 human glioma cells. Neurochem Res 37:2667-2677.
32. Latini S, Pedata F. 2001. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem 79:463-84.
33. Lauro C, Di Angelantonio S, Cipriani R, Sobrero F, Antonilli L, Brusadin V, Ragozzino D, Limatola C. 2008. Activity of adenosine receptors type 1 Is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons. J Immunol 180:7590-7596.
34. Lee WT, Hong S, Yoon SH, Kim JH, Park KA, Seong GJ, Lee JE. 2009. Neuroprotective effects of agmatine on oxygen-glucose deprived primary-cultured astrocytes and nuclear translocation of nuclear factor-kappa B. Brain Res 1281:64-70.
35. Martin ED, Fernandez M, Perea G, Pascual O, Haydon PG, Araque A, Cena V. 2007. Adenosine released by astrocytes contributes to hypoxia-induced modulation of synaptic transmission. Glia 55:36-45.
36. Mato S, Sánchez-Gómez MV, Bernal-Chico A, Matute C. 2013. Cytosolic zinc accumulation contributes to excitotoxic oligodendroglial death. Glia 61:750-764.
37. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
38. Meester BJ, Shankley NP, Welsh NJ, Meijler FL, Black JW. 1998. Pharmacological analysis of the activity of the adenosine uptake inhibitor, dipyridamole, on the sinoatrial and atrioventricular nodes of the guinea-pig. Br J Pharmacol 124:729-741.
39. Melani A, Cipriani S, Vannucchi MG, Nosi D, Donati C, Bruni P, Giovannini MG, Pedata F. 2009. Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia. Brain 132:1480-1495.
40. Mills JH, Thompson LF, Mueller C, Waickman AT, Jalkanen S, Niemela J, Airas L, Bynoe MS. 2008. CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 105:9325-9330.
41. Miyazaki N, Nakatsuka T, Takeda D, Nohda K, Inoue K, Yoshida M. 2008. Adenosine modulates excitatory synaptic transmission and suppresses neuronal death induced by ischaemia in rat spinal motoneurones. Pflugers Arch 457:441-451.
42. O'Meara RW, Michalski JP, Kothary R. 2011. Integrin signaling in oligodendrocytes and its importance in CNS myelination. J Signal Transduct 2011:354091.
43. Othman T, Yan H, Rivkees SA. 2003. Oligodendrocytes express functional A1 adenosine receptors that stimulate cellular migration. Glia 44:166-172.
44. Otsuki T, Kanno T, Fujita Y, Tabata C, Fukuoka K, Nakano T, Gotoh A, Nishizaki T. 2012. A3 adenosine receptor-mediated p53-dependent apoptosis in Lu-65 human lung cancer cells. Cell Physiol Biochem 30:210-220.
45. Pedata F, Melani A, Pugliese AM, Coppi E, Cipriani S, Traini C. 2007. The role of ATP and adenosine in the brain under normoxic and ischemic conditions. Purinergic Signal 3:299-310
46. Pugliese AM, Traini C, Cipriani S, Gianfriddo M, Mello T, Giovannini MG, Galli A, Pedata F. 2009. The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen-glucose deprivation in rat CA1 hippocampal slices. Br J Pharmacol 157:818-830.
47. Ragab S, Lunt M, Birch A, Thomas P, Jenkinson DF. 2004. Caffeine reduces cerebral blood flow in patients recovering from an ischaemic stroke. Age Ageing 33:299-303.
48. Ren D, Tu HC, Kim H, Wang GX, Bean GR, Takeuchi O, Jeffers JR, Zambetti GP, Hsieh JJ, Cheng EH. 2010. BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program. Science 330:1390-1393.
49. Ribeiro JA, Sebastião AM, de Mendonça A. 2002. Adenosine receptors in the nervous system: Pathophysiological implications. Prog Neurobiol 68:377-392.
50. Riksen NP, Zhou Z, Oyen WJ, Jaspers R, Ramakers BP, Brouwer RM, Boerman OC, Steinmetz N, Smits P, Rongen GA. 2006. Caffeine prevents protection in two human models of ischemic preconditioning. J Am Coll Cardiol 48:700-707.
51. Sai K, Yang D, Yamamoto H, Fujikawa H, Yamamoto S, Nagata T, Saito M, Yamamura T, Nishizaki T. 2006. A(1) adenosine receptor signal and AMPK involving caspase-9/-3 activation are responsible for adenosine-induced RCR-1 astrocytoma cell death. Neurotoxicology 27:458-467.
52. Sánchez-Gómez MV, Alberdi E, Ibarretxe G, Torre I, Matute C. 2003. Caspase-dependent and caspase-independent oligodendrocyte death mediated by AMPA and kainate receptors. J Neurosci 23:9519-9528.
53. Sánchez-Gómez MV, Alberdi E, Perez-Navarro E, Alberch J, Matute C. 2011. Bax and calpain mediate excitotoxic oligodendrocyte death induced by activation of both AMPA and kainate receptors. J Neurosci 31:2996-3006.
54. Sánchez-Gómez MV, Matute C. 1999. AMPA and kainate receptors each mediate excitotoxicity in oligodendroglial cultures. Neurobiol Dis 6:475-485.
55. Schwarzschild MA. 2007. Adenosine A2A antagonists as neurotherapeutics: Crossing the bridge. Prog Neurobiol 83:261-262.
56. Shibata M, Hisahara S, Hara H, Yamawaki T, Fukuuchi Y, Yuan J, Okano H, Miura M. 2000. Caspases determine the vulnerability of oligodendrocytes in the ischemic brain. J Clin Invest 106:643-653.
57. Smith KJ, Lassmann H. 2002. The role of nitric oxide in multiple sclerosis. Lancet Neurol 1:232-241.
58. Steckley D, Karajgikar M, Dale LB, Fuerth B, Swan P, Drummond-Main C, Poulter MO, Ferguson SS, Strasser A, Cregan SP. 2007. Puma is a dominant regulator of oxidative stress induced Bax activation and neuronal apoptosis. J Neurosci 27:12989-12999.
59. Stevens B, Porta S, Haak LL, Gallo V, Fields RD. 2002. Adenosine: A neuron-glial transmitter promoting myelination in the CNS in response to action potentials. Neuron 36:855-868.
60. Tekkok SB, Ye Z, Ransom BR. 2007. Excitotoxic mechanisms of ischemic injury in myelinated white matter. J Cereb Blood Flow Metab 27:1540-1552.
61. Tourneur L, Mistou S, Schmitt A, Chiocchia G. 2008. Adenosine receptors control a new pathway of Fas-associated death domain protein expression regulation by secretion. J Biol Chem 283:17929-17938.
62. Trincavelli ML, Melani A, Guidi S, Cuboni S, Cipriani S, Pedata F, Martini C. 2008. Regulation of A(2A) adenosine receptor expression and functioning following permanent focal ischemia in rat brain. J Neurochem 104:479-490.
63. Tsutsui S, Schnermann J, Noorbakhsh F, Henry S, Yong VW, Winston BW, Warren K, Power C. 2004. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J Neurosci 24:1521-1529.
64. Walker EJ, Rosenberg GA. 2010. Divergent role for MMP-2 in myelin breakdown and oligodendrocyte death following transient global ischemia. J Neurosci Res 88:764-773.
65. Wei W, Du C, Lv J, Zhao G, Li Z, Wu Z, Hasko G, Xie X. 2013. Blocking A2B adenosine receptor alleviates pathogenesis of experimental autoimmune encephalomyelitis via inhibition of IL-6 production and Th17 differentiation. J Immunol 190:138-146.
66. Xu Z, Park SS, Mueller RA, Bagnell RC, Patterson C, Boysen PG. 2005. Adenosine produces nitric oxide and prevents mitochondrial oxidant damage in rat cardiomyocytes. Cardiovasc Res 65:803-812.
67. Yang Y, Jalal FY, Thompson JF, Walker EJ, Candelario-Jalil E, Li L, Reichard RR, Ben C, Sang QX, Cunningham LA and others. 2011. Tissue inhibitor of metalloproteinases-3 mediates the death of immature oligodendrocytes via TNF-alpha/TACE in focal cerebral ischemia in mice. J Neuroinflammation 8:108.
68. Yao Y, Sei Y, Abbracchio MP, Jiang JL, Kim YC, Jacobson KA. 1997. Adenosine A3 receptor agonists protect HL-60 and U-937 cells from apoptosis induced by A3 antagonists. Biochem Biophys Res Commun 232:317-322.